Among companies that didn't cover abortion services or had limited coverage, 3% reduced abortion coverage, and, of the large companies that generally covered abortion, only 12% expanded coverage, says a KFF survey.

Even though six drug companies have filed lawsuits to halt the Medicare drug negotiation program, the companies have until Oct. 2 to present data on their drugs to CMS, which will make initial price offers in February.

When the public health emergency ends on May 11, it will institute sweeping changes across the health care system, from hospitals and testing labs to treatment for people recovering from addiction.

Just about every industry is struggling to find workers, but staffing shortages in state Medicaid agencies have come at a challenging time.

South Carolina's junior senator is someone widely viewed as destined for greater things during his political career.

While legislation has taken aim at insulin prices, the measures do not address the widespread problem of escalating drug prices across the board.

As Congress begins its 2020 session, the bills with the most momentum are making more and more concessions to physicians.